Table 3 Comparative analysis according to the intraoperative assessment results, n = 222

Age^a

53.7 ± 11.4

56 ± 12.2

0.166

Menopause

108 (76%)

62 (77.5%)

0.807

Weight, kg^b

74.5 (65.5-85.5)

68.5 (60-80.5)

0.079

BMI^a

32.6 ± 6.7

31.1 ± 7.1

0.131

 I

120 (84.5%)

42 (52.5%)

< 0.001

 II

12 (8.5%)

13 (16.3%)

 III

8 (5.6%)

22 (27.5%)

 IV

2 (1.4%)

3 (3.8%)

Lymph node metastasis

7 (4.9%)

16 (20%)

< 0.001

Lymphadenectomy

18 (12.7%)

69 (86.3%)

< 0.001

Bleeding, ml^b

150 (80-300)

375 (200-550)

< 0.001

Transfusion

0 (0%)

8 (10%)

< 0.001

Reintervention

2 (1.4%)

3 (3.8%)

0.277

ICU

2 (1.4%)

5 (6.3%)

0.07

Adjuvant therapy

44 (31%)

62 (77.5%)

< 0.001

 Radiotherapy

41 (28.9%)

58 (72.5%)

0.94

 Chemotherapy

8 (5.6%)

22 (27.5%)

0.049

Recurrence of disease

7 (4.9%)

8 (10%)

0.156